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Abstract
Background: Myocardial infarction (MI) is a leading cause of disease with high morbidity and mor-
tality worldwide. Recent studies have revealed that long non-coding RNAs (lncRNAs) are involved in 
heart disease pathogenesis. This study aimed to investigate the effect and the molecular basis of THRIL 
on hypoxia-injured H9C2 cells. 
Methods: THRIL, miR-99a and Brahma-related gene 1 (Brg1) expressions in H9C2 cells were altered 
by transient transfections. The cells were subjected to hypoxia for 4 h, and then the levels of THRIL, 
miR-99a and Brg1 were investigated. Cell viability, migration and invasion, and apoptotic cells were re-
spectively measured by trypan blue exclusion assay, transwell migration assay and flow cytometry assay. 
Dual luciferase reporter assay was conducted to verify the interaction between miR-99a and THRIL. 
Furthermore, levels of apoptosis-, PI3K/AKT and mTOR pathways-related factors were measured by 
western blotting.
Results: Hypoxia induced an increase of THRIL but a reduction of miR-99a and Brg1. THRIL 
inhibition significantly attenuated hypoxia-induced cell injuries, as increased cell viability, migration 
and invasion, and decreased cell apoptosis. THRIL negatively regulated miR-99a expression through 
sponging with miR-99a binding site, and miR-99a inhibition abolished the protective effects of THRIL 
knockdown against hypoxia-induced injury in H9C2 cells. Furthermore, miR-99a positively regulated 
the expression of Brg1. Brg1 inhibition promoted hypoxia-induced cell injuries, while Brg1 overexpres-
sion alleviated hypoxia-induced cell injuries. Moreover, Brg1 overexpression activated PI3K/AKT and 
mTOR pathways. 
Conclusions: This study demonstrated that THRIL inhibition represented a protective effect against 
hypoxia-induced injuries in H9C2 cells by up-regulating miR-99a expression. (Cardiol J 2019; 26, 5: 
564–574)
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Introduction
Ischemic heart disease, such as myocardial in-
farction (MI), poses a major threat to human health 
and is one of the leading causes of diseases with 
high morbidity and mortality worldwide [1]. MI is 
mainly caused by a life-threatening interruption of 
blood supply to  part of the heart [2]. Despite rapid 
progress obtained in targeted therapy strategies 
and improvement of life quality of patients, there 
still remain limitations in the clinical treatment and 
prevention of MI. Thus, it is of great significance 
to understand further mechanisms of physiological 
and pathological processes in MI.
Non-coding RNAs (ncRNAs) are classified into 
small ncRNAs and long ncRNAs (lncRNAs) ac-
cording to their size. Small ncRNAs, such as short 
interfering RNAs (siRNAs), piwi-interactingRNA 
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(piRNAs), and microRNAs (miRNAs) that have 
a length of less than 200 nucleotides (nt) [3]. 
LncRNAs are nonprotein coding transcripts with 
length longer than 200 nucleotides, and many of 
which are emerged as an important class of regula-
tory molecules in governing fundamental biological 
processes [4]. The mechanism of gene regulation 
by lncRNAs are involved in activation or inhibition 
of gene expression and modulation of chromatin 
architecture [5]. Recent studies have revealed 
that a number of lncRNAs have significant roles 
in a diverse range of cellular functions including 
development, differentiation, and cell fate as well 
as disease pathogenesis [3, 6, 7]. In the cardio-
vascular system, it has been reported that several 
lncRNAs, such as Novlnc6 and Mhrt, are involved 
in acute MI and heart failure; whereas others 
(such as CARL, CHRF, Novlnc6 and et al.) control 
hypertrophy, mitochondrial function and apoptosis 
of cardiomyocytes [8]. THRIL (TNFa and hn-
RNPL related immunoregulatory lincRNA) is first 
reported to regulate lipopolysaccharide-induced 
tumor necrosis factor alpha (TNFa) by interacting 
with heterogenous nuclear ribonucleoprotein L 
(hnRNPL), and plays a crucial role in the regula-
tion of physiological and pathological inflammatory 
immune responses [9]. However, its biological 
role and regulatory mechanism in hypoxia-induced 
injury of H9C2 cells are poorly defined.
In the present study, the role of THRIL in 
the survival and metastasis of H9C2 cells against 
hypoxia stimulus as well as the underlying mecha-
nism is investigated. It was found that THRIL 
knockdown attenuated hypoxia-induced cell inju-
ries in H9C2 cells. THRIL negatively regulated 
miR-99a expression through sponging with its 
banding site. In addition, we also proved that 
Brahma-related gene 1 (Brg1) expression was posi-
tively regulated by miR-99a and Brg1 was involved 
in the hypoxia-induced injuries in H9C2 cells. This 
study will provide new insight into the fundamental 
information and novel pharmacological target for 
therapeutic approaches of cardiovascular disease. 
Methods
Cell culture and hypoxia treatment
H9C2 cells, obtained from the American Type 
Culture Collection (ATCC; Rockville, MD, USA), 
were cultured in Dulbecco’s modified Eagle’s me-
dium (DMEM; HyClone, Logan, UT, USA) supple-
mented with 10% fetal bovine serum (FBS; Gibco, 
Gaithersburg, MD, USA), 100 U/mL penicillin and 
100 μg/mL streptomycin (Life Technologies Corpo-
ration, Carlsbad, CA, USA) at 37°C in an atmosphere 
of 95% air and 5% CO2. When cells reached about 
80% of confluence in appropriate culture dishes, 
cells were pre-starved using DMEM supplemented 
with 0.5% FBS for 1 h and then were incubated in 
hypoxic incubator containing 94% N2, 5% CO2, and 
1% O2 for 4 h to simulate hypoxia injury.
Transfection and generation of  
stably transfected cell lines
Short-hairpin RNA (shRNA) directed against 
human lncRNA THRIL was ligated into the U6/
GFP/Neo plasmid (GenePharma, Shanghai, China) 
and was referred as to sh-THRIL. The plasmid 
PGPU6/GFP/neo-shControl (GenePharma) was 
used as the negative control (NC) and encoded with 
a nonsense sequence, and was referred as to sh-
NC. For the analysis of the Brg1 functions, the full-
length Brg1 sequences and shRNA directed against 
Brg1 were constructed in pEX-2 and U6/GFP/Neo 
plasmids (GenePharma), respectively. And they 
were referred as to pEX-Brg1 and sh-Brg1. The 
plasmid carrying a non-targeting sequence was 
used as a NC of pEX-Brg1 and sh-Brg1, which were 
referred as to pEX and sh-NC. The lipofectamine 
3000 reagent (Life Technologies Corporation) was 
used for cell transfection according to the manu-
facturer instructions. The stably transfected cells 
were selected by the culture medium containing 
0.5 mg/mL G418 (Sigma-Aldrich, St. Louis, MO, 
USA). After approximately 4 weeks, G418-resistant 
cell clones were established. miR-99a mimic, in-
hibitor and their respective NC were synthesized 
(Life Technologies Corporation) and transfected 
into cells in the study. Since the highest transfec-
tion efficiency occurred at 48 h, thus 72 h post-
transfection was considered as the harvest time 
in the subsequent experiments.
Quantitative real-time PCR
Total RNA was extracted from cells using 
TRIzol reagent (Life Technologies Corporation) 
according to the manufacturer instructions. RNA 
was reverse transcribed to cDNA using a Reverse 
Transcription Kit (Takara, Dalian, China). THRIL 
and Brg1 expression levels were determined by 
quantitative real time polymerase chain reaction 
(qRT-PCR) using the SYBR Green Master Mix 
(Takara). The expression of miR-99a was measured 
using Taqman MicroRNA Assay (Applied Biosys-
tems, Foster City, CA, USA) according to manufac-
turer instructions. GAPDH and U6 were used for 
the normalization of mRNA, lncRNA and miRNA. 
The results were presented as fold changes rela-
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tive to U6 or GAPDH and were calculated using 
the 2–DDCT method. The primer sequences used in 
qRT-PCR analysis were shown as follows: lncRNA 
THRIL (Forward: 5’-GAG TGC AGT GGC GTG 
ATC TC-3’, Reverse: 5’-AAA ATT AGT CAG GCA 
TGG TGG TG-3’); miR-99a (Forward: 5’-CGG AAC 
CCG TAG ATC CGA T-3’, Reverse: 5’-CAG TGC 
AGG GTC CGA GGT-3’); Brg1 (Forward: 5’-CCT 
CTC TCA ACG CTG TCC AAC TG-3’, Reverse: 
5’-ATC TTG GCG AGG ATG TGC TTG TCT T-3’).
Cell viability assay
For cell viability assay, 1 × 105 cells were 
seeded in duplicate in 60-mm dishes. After 4 h for 
hypoxia followed by 72 h transfection, cells were 
washed with phosphate buffered saline (PBS) and 
living cell numbers were determined by trypan 
blue exclusion (Beyotime Biotechnology, Shanghai, 
China) as previously described [10].
Apoptosis assay
For apoptosis assay, cells were stained with 
propidium iodide (PI) and fluorescein-isothio-
cyanate (FITC) — conjugated Annexin V using 
an Annexin V-FITC/PI Apoptosis Detection Kit 
(Beyotime Biotechnology). Briefly, the cells were 
harvested after transfection in 72 h and 4 h for 
hypoxia incubation and then centrifuged at 800 g 
for 5 min at 4°C. Cells were washed with PBS 3 
times and resuspended with 500 μL 1 × binding 
buffer. Then cells were mixed with 5 μL Annexin 
V-FITC and 5 μL PI for 15 min in the dark at 37°C. 
Flow cytometry analysis was done using a FACS 
can (Beckman Coulter, Fullerton, CA, USA). The 
data were analyzed using FlowJo software (Tree 
Star Inc., Ashland, OR).
Migration and invasion assay
Cell migration and invasion was measured 
using a transwell chamber (8 μm, 24-well format; 
Corning, Lowell, MA, USA). For migration assay, 
1 × 105 cells in 0.2 mL of serum-free medium 
were plated on the upper compartment of 24-well 
transwell culture chamber, and 0.6 mL of medium 
containing 10% FBS was added to the lower 
chamber. For invasion assay, 1.5 × 105 cells were 
planted on the upper chamber which is pre-coated 
with 20 μg of Matrigel (BD Biosciences, Bedford, 
MA, USA). After 48 h of incubation, the migrated 
and invaded cells in the lower chamber were fixed 
in 100% methanol and stained with 0.1% crystal 
violet (Sigma-Aldrich) and cells that did not mi-
grate or invade through the pores were removed 
by cotton swabs. The migrated and invaded cells 
were counted in 5 random fields and expressed as 
the average number of cells per field. These ex-
periments were done in triplicate and performed 
a minimum of three times.
Reporter vectors constructs and  
luciferase reporter assay
The segment from the 3’-UTR of the THRIL 
containing the predicted miR-99a binding site was 
amplified by PCR and then cloned into a pmirGlO 
Dual-luciferase miRNA Target Expression Vector 
(Promega, Madison, WI, USA) to form the reporter 
vector THRIL-wild-type (THRIL-wt). To mutate 
the putative binding site of miR-99a in the THRIL, 
the sequence of putative binding site was replaced 
and was named as THRIL-mutated-type (THRIL-
-mt). Then the vector and miR-99a mimic were 
co-transfected into H9C2 cells with lipofectamine 
3000 (Life Technologies Corporation), and the 
Dual-Luciferase Reporter Assay System (Promega) 
were used for detecting the luciferase activity.
Western blot
Cells were homogenized in RIPA protein lysis 
buffer (Beyotime Biotechnology) supplemented 
with protease inhibitors (Roche, Basel, Switzer-
land) at 4°C for 30 min before centrifugation at 
12,000 g for 15 min at 4°C. The protein concentra-
tion was quantified using the BCA Protein Assay 
Kit (Pierce, Rockford, IL, USA). Denatured sam-
ples (20–40 μg of protein) were loaded into each 
well, separated by 10–12% sodium dodecyl sulfate-
polyacrylamide gel (SDS-PAGE), and transferred 
to a polyvinylidene difluoride (PVDF) membrane 
(Millipore, Billerica, MA). Subsequently, the mem-
brane was blocked in 5% BSA (Roche) in TBST at 
room temperature for 1 h. Primary antibodies: anti-
Bcl-2 (#4223), anti-Bax (#5023), anti-caspase-3 
(#9662), anti-caspase-9 (#9502), anti-GAPDH 
(#2118), anti-Brg1 (#49360), anti-PI3K (#4249), 
anti-p-PI3K(#4228), anti-AKT (#4685), anti-p-
AKT (#4060), anti-mTOR (#2983), anti-p-mTOR 
(#5536), anti-p70S6K (#2708), and anti-p-p70S6K 
(#9204, Cell Signaling Technology, Beverly, MA, 
USA) were prepared in 5% BSA at a dilution of 
1:1000. The blot was incubated respectively with 
primary antibodies overnight at 4°C. After wash-
ing with TBST for 3 times, the membranes were 
further incubated with horseradish peroxidase-
conjugated goat anti-rabbit IgG or anti-mouse IgG 
(Sigma-Aldrich) at a 1:5000 dilution for 2 h at room 
temperature. The blots were developed with ECL 
solution (Pierce) and visualized by using Image 
Lab™ Software (Bio-Rad, Hercules, CA, USA).
www.cardiologyjournal.org 567
Jingwen Xia et al., The role of THRIL in hypoxia-injured H9C2 cells
Statistical analysis
All experiments were repeated 3 times. The 
results of multiple experiments are presented as 
the mean ± standard deviation (SD). Statistical 
analyses were performed using Graphpad 6.0 sta-
tistical software (GraphPad Software, San Diego, 
CA, USA). The p-values were calculated using 
a one-way analysis of variance (ANOVA). A p-value 
of < 0.05 was considered to indicate a statistically 
significant result.
Results
Hypoxia induced the increase of THRIL 
but the reduction of miR-99a and Brg1
H9C2 cells were exposed to hypoxia incubator 
for 4 h to stimulate hypoxia injury. As shown in Fig-
ure 1A, the expression of THRIL was significantly 
up-regulated by hypoxia treatment in H9C2 cells 
(p < 0.01). However, hypoxia treatment induced 
a significant reduction of miR-99a expression (p < 
< 0.05; Fig. 1B). In addition, the protein and mRNA 
expression of Brg1 was also down-regulated by 
hypoxia injury in H9C2 cells (p < 0.05; Fig. 1C, D).
THRIL knockdown attenuated hypoxia-
-induced cell injuries in H9C2 cells 
To analyze the potential role of THRIL knock-
down in hypoxia-induced injuries in H9C2 cells, we 
transfected THRIL targeted shRNA (sh-THRIL) 
into H9C2 cells to induce silence of THRIL and 
the efficiency of transfection was performed by 
qRT-PCR analysis (Fig. 2A). As expected, the 
expression level of THRIL was significantly re-
duced after transfection with sh-THRIL in H9C2 
cells (p < 0.01). As the migration of cardiomyo-
cytes into the injury site has been reported to be 
regulated independently of proliferation, and that 
coordination of both processes is necessary for 
heart regeneration [11], thus not only the effect of 
THRIL knockdown on cell viability and apoptosis 
was investigated, but also the migration and inva-
sion of H9C2 cells were examined. As shown in 
Figure 2B–E, there was a significant reduction of 
cell viability, relative migration and invasion (all 
p < 0.01), while an increase of cell apoptotic rate 
in H9C2 cells after hypoxia treatment (p < 0.001). 
Consistently, hypoxia treatment induced the up-
regulation of pro-apoptotic proteins including Bax, 
Cleaved capase-3 and Cleaved caspase-9, and the 
down-regulation of Bcl-2 (Fig. 2F). Interestingly, 
THRIL knockdown significantly increased the cell 
viability, migration and invasion, and declined apop-
totic cell rate after hypoxia treatment (all p < 0.05) 
(Fig. 2B–E). Besides, THRIL inhibition decreased 
pro-apoptotic proteins levels and increased Bcl-2 
levels in hypoxia-exposed H9C2 cells (Fig. 2F). 
Taken together, these results indicated that THRIL 
inhibition exerted a protective effect on hypoxia-
induced cell injuries in H9C2 cells.
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Figure 1. Hypoxia induced an increase of THRIL but the reduction of miR-99a and Brahma-related gene 1 (Brg1). H9C2 
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miR-99a was negatively  
regulated by THRIL
As it was found that hypoxia treatment up-
regulated expression of THRIL but down-regulated 
the expression of miR-99a, it was hypothesized as 
to whether there was a relationship between those 
two genes. By seeking bioinformatics online data-
bases including TargetScan (http://www.targetscan.
org/vert_71/) and NCBI (https://www.ncbi.nlm.nih.
gov/), and using the bioinformatics method, lncRNA 
THRIL was predicted to bind to miR-99a. The pre-
dicted banding sequences were shown in Figure 3A. 
Thus, it was speculated that there might be an 
interaction between THRIL and miR-99a in H9C2 
cells. To verify whether THRIL has a direct interac-
tion with miR-99a, a dual-luciferase reporter sys-
tem was employed by co-transfection of miR-99a 
and luciferase reporter plasmids containing 
3’-UTR of THRIL, or mutated THRIL (bearing 
deletions of the putative miR-99a target sites). 
The dual-luciferase reporter assay revealed that 
co-transfection of miR-99a mimic and THRIL-wt 
specifically decreased the luciferase activity 
(p < 0.05), and there was no significant difference 
between co-transfection with miR-99a mimic and 
THRIL-mt in H9C2 cells (p > 0.05) (Fig. 3B), 
which suggested that THRIL might function 
as endogenous sponge RNA to interact with 
miR-99a. As shown in Figure 3C, THRIL inhibi-
tion up-regulated the expression of miR-99a in 
H9C2 cells (p < 0.001). These findings indicated 
that THRIL negatively regulated the expression 
of miR-99a through sponging with miR-99a in 
H9C2 cells.
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THRIL knockdown alleviated hypoxia-
-induced cell injuries through up-regulation 
of miR-99a in H9C2 cells
Further, exploring whether THRIL regu-
lated hypoxia-induced cell injuries through tar-
geting miR-99a. miR-99a expression in H9C2 
cells were altered by transfection with miR-99a 
mimic or miR-99a inhibitor. As shown in Figure 
4A, B, the expression miR-99a was dramatically 
up-regulated after transfection with miR-99a 
mimic, but was down-regulated with miR-99a 
inhibitor (p < 0.01, or p < 0.001). miR-99a in-
hibitor blocked the protective effects of THRIL on 
hypoxia-induced cell injuries, as miR-99a inhibition 
significantly decreased cell viability (p < 0.01; 
Fig. 4C), suppressed cell migration and invasion 
(p < 0.01; Fig. 4D, E), and promoted apoptotic cell 
rates (p < 0.05; Fig. 4F). Furthermore, the effect 
of THRIL suppression on apoptosis related proteins 
was reversed by miR-99a inhibition in H9C2 cells 
(Fig. 4G). Overall, these results indicate that THRIL 
knockdown alleviated hypoxia-induced cell injuries 
through up-regulation of miR-99a in H9C2 cells.
Brg1 was positively regulated by miR-99a
Given that, Brg1 is required for cell prolifera-
tion to form the compact and septal myocardium 
[12]. Cross-regulation was detected between 
miR-99 and Brg1, to further reveal the mechanism(s) 
via which miR-99a modulated H9C2 cells. It was 
found that miR-99a inhibition declined both the 
protein and mRNA levels of Brg1 (p < 0.05; 
Fig. 5A, C). Of contrast, miR-99a mimic elevated 
Brg1 levels in H9C2 cells (p < 0.01; Fig. 5B, D). 
Taken together, these results indicated that Brg1 
was positively regulated by miR-99a in H9C2 cells. 
Brg1 was involved in hypoxia-induced  
cell injuries in H9C2 cells
To investigate whether Brg1 was required 
for hypoxia-induced cell injuries in H9C2 cells, 
H9C2 cells were transfected with overexpressing-
vector and shRNA specific targeted Brg1. As 
shown in Figure 6A, B, the protein and mRNA 
levels of Brg1 were significantly up-regulated 
in H9C2 cells after transfection with pEX-Brg1 
(p < 0.001), while were down-regulated in cells 
which were transfected with sh-Brg1 (p < 0.001). 
Results revealed that Brg1 inhibition promoted 
hypoxia-induced cell injuries, as decreased cell 
viability (p < 0.05; Fig. 6C), cell migration and 
invasion (p < 0.05, or p < 0.01; Fig. 6D, E), 
and induced apoptosis (p < 0.01; Fig. 6F, G). 
Of contrast, inverse regulations were found in 
cells which were transfected with pEX-Brg1 
(all p < 0.05; Fig. 6C, G). These results suggested 
that Brg1 was involved in hypoxia-induced cell 
injuries in H9C2 cells.
Brg1 regulated PI3K/AKT and mTOR  
signaling pathways
miR-99a has been identified to regulate PI3K/ 
/AKT and mTOR signaling pathways [13, 14]. 
Here, the effect of Brg1 overexpression on PI3K/ 
/AKT and mTOR signaling pathways in H9C2 cells 
was explored. As shown in Figure 7A, hypoxia sup-
pressed the activation of PI3K and AKT. However, 
Brg1 overexpression increased the levels of p-PI3K 
and p-AKT, indicating the activated effect of PI3K/ 
/AKT signaling pathway. Furthermore, it was found 
that Brg1 also activated mTOR signaling pathway, 
as increased expression of p-mTOR and p-p70S6K 
(Fig. 7B).
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Figure 4. THRIL knockdown alleviated hypoxia-induced cell injuries through up-regulation of miR-99a in H9C2 cells. 
H9C2 cells were transfected with miR-99a mimic, miR-99a inhibitor or their corresponding controls, i.e., mimic control 
and inhibitor control, or co-transfected with 99a inhibitor and sh-THRIL. Cells were incubated in hypoxic incubator 
for 4 h to simulate hypoxia. A, B. The expression of miR-99a was assessed by quantitative real time polymerase 
chain reaction. Cell viability (C), relative migration (D) and invasion (E), apoptotic cells rate (F), and the expression 
of apoptosis-related factors (G) were respectively assessed by trypan blue exclusion assay, transwell analysis, flow 
cytometry, and Western blotting; *p < 0.05; **p < 0.01, ***p < 0.001.
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Discussion
Myocardial hypoxia triggers cell injuries, 
which is associated with the pathogenesis of many 
cardiovascular diseases including heart failure, MI, 
myocardial ischemia as well as reperfusion injury 
[15]. The present data indicated that miR-99a 
was negatively regulated by THRIL, and THRIL 
knockdown alleviated hypoxia-induced cell injuries 
through up-regulation of miR-99a in H9C2 cells. 
Moreover, it was shown that Brg1 was positively 
regulated by miR-99a, and was involved in hypoxia-
-induced cell injuries in H9C2 cells. These data 
suggested that THRIL may play a crucial role in hy-
poxia-induced cell injuries via regulating miR-99a 
in H9C2 cells.
LncRNAs have been defined to have impor-
tant functions in various cellular processes such 
as genomic imprinting, cell fate determination, 
RNA processing, chromatin modification, modula-
tion of apoptosis and invasion, and is important 
for development, differentiation and metabolism 
[16–19]. Emerging evidences have reported that 
lncRNAs are essential for the development of 
cardiomyocytes [20–22]. For example, the lateral 
mesoderm-specific lncRNA Fendrr is an essential 
regulator of the fate of lateral mesoderm deriva-
tives, specifically the heart and the body wall in 
mice [23]. APF regulates autophagy and MI by tar-
geting miR-188-3p [18]. Recent evidence suggests 
that THRIL is associated with TNFa regulation 
and may contribute to other common inflamma-
tory diseases [9]. Another report showed that 
THRIL regulates helicobacter pylori cagA induced-
inflammation in gastric cancer cells via inhibition of 
NF-kB translocation [24]. However, the potential role 
of THRIL in regulating hypoxia-induced injuries in 
H9C2 cells have not been elucidated. The present 
results revealed that THRIL knockdown functioned 
as a protector against hypoxia-induced injuries in 
H9C2 cells, as increased cell viability, cell migra-
tion and invasion, and reduced cell apoptosis.
Recently, lncRNAs have been identified as 
competing endogenous RNAs to sponge miRNAs 
thus modulating the depression of miRNA targets 
and imposing an additional level of post-tran-
scriptional regulation [25, 26]. miR-99a has been 
demonstrated to play an important role in cardio-
myogenesis. Recent evidence showed that miR-99a 
expression significantly declined in patients with 
MI, and overexpression of miR-99a attenuated 
ventricular remodeling, cardiac hypertrophy and 
improved cardiac performance after MI [27–29]. 
In the present study, it was found that THRIL 
negatively regulated the expression of miR-99a, 
and THRIL acted as a sponge of miR-99a in H9C2 
cells. Furthermore, we also found that THRIL 
inhibition alleviated hypoxia-induced cell injuries 
through up-regulation of miR-99a in H9C2 cells. 
Brg1 is one of the central ATPase catalytic 
subunits, which is essential for zygote genome 
activation, erythropoiesis, cardiac development 
Figure 5. Brahma-related gene 1 (Brg1) was positively regulated by miR-99a. H9C2 cells were transfected with miR-99a 
mimic, miR-99a inhibitor or their corresponding controls, i.e., mimic control and inhibitor control; then the (A, B) 
mRNA and (C, D) protein expressions of Brg1 were assessed by quantitative real time polymerase chain reaction and 
Western blotting; *p < 0.05, **p < 0.01.
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Figure 6. Brahma-related gene 1 (Brg1) was involved in hypoxia-induced cell injuries in H9C2 cells. H9C2 cells were 
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in hypoxic incubator for 4 h to simulate hypoxia. A, B. The mRNA and protein expression of Brg1 were detected by 
quantitative real time polymerase chain reaction (qRT-PCR) and Western blotting. Cell viability (C), relative migra-
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tively assessed by trypan blue exclusion assay, transwell analysis, flow cytometry, and Western blotting; *p < 0.05; 
**p < 0.01; ***p < 0.001.
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and neuronal development [30]. In embryos, Brg1 
promotes cardiomyocyte proliferation by main-
taining Bmp10 and suppressing p57kip2 expres-
sion. However, in adults, Brg1 is turned off in 
cardiomyocytes and it is reactivated by cardiac 
stresses, and preventing Brg1 re-expression de-
creases hypertrophy [31]. Zebrafish experiment 
also showed that Brg1 promotes heart regeneration 
by repressing cyclin-dependent kinase inhibitors 
partly through Dnmt3ab-dependent DNA methyla-
tion [30]. Results herein showed that Brg1 was 
positively regulated by miR-99a in H9C2 cells, 
and overexpression of Brg1 attenuated hypoxia-
induced cell injuries. It was supposed that THRIL 
may sponge with miR-99a and that miR-99a further 
regulate Brg1, thus regulating hypoxia-induced 
injury in H9C2 cells. However, further study is 
needed to confirm this hypothesis. In addition, it 
was also found that overexpression of Brg1 acti-
vated PI3K/AKT and mTOR signaling pathways. 
The PI3K/AKT and mTOR signaling pathways are 
important signal transduction pathways that control 
cardiomyocyte survival and functions [32, 33]. The 
activation of PI3K/AKT and mTOR pathways may 
contribute to inhibiting myocardial cells apoptosis 
and promoting cell survival in a damaged heart 
[34, 35]. It has been reported that Brg1 promotes 
osteogenic differentiation of mesenchymal stem 
cells (MSCs), and the mechanism might be by 
regulating Runx2-mediated downstream Wnt and 
PI3K/AKT pathways. Brg1 overexpression sta-
tistically increased the expression of PI3K/AKT 
pathways key proteins [36]. Present results are 
consistent with previous reports about regulation 
of Brg1 on PI3K/AKT and mTOR pathway, and 
these data suggest that miR-99a overexpression 
might activate the PI3K/AKT and mTOR signaling 
pathways through up-regulated Brg1.
Conclusions
In conclusion, the present study demonstrat-
ed that THRIL knockdown attenuated hypoxia-
induced injuries of H9C2 cells through directly 
up-regulated expression of miR-99a. Interestingly, 
miR-99a positively regulated Brg1 expression, and 
Brg1 overexpression exerted similarly protective 
effects to THRIL inhibition. According to available 
research, this is the first study to demonstrate that 
THRIL is associated with hypoxia-induced injuries 
of H9C2 cells, which direct sponging with miR-99a. 
It was also revealed that Brg1 was positively regu-
lated by miR-99a in H9C2 cells for the first time. It 
may allow a better understanding of the pathologi-
cal process of MI and ultimately contribute to the 
development of THRIL-directed diagnostics and 
therapeutics against myocardial infarction.
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